Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E24.18 EPS (ttm)1.40 Insider Own0.50% Shs Outstand2.53B Perf Week1.32%
Market Cap85.66B Forward P/E20.68 EPS next Y1.64 Insider Trans0.00% Shs Float2.50B Perf Month-1.11%
Income3.54B PEG3.56 EPS next Q0.45 Inst Own15.50% Short Float0.59% Perf Quarter14.79%
Sales22.27B P/S3.85 EPS this Y23.80% Inst Trans3.15% Short Ratio3.68 Perf Half Y-1.49%
Book/sh5.42 P/B6.24 EPS next Y-15.15% ROA5.60% Target Price36.67 Perf Year28.00%
Cash/sh2.06 P/C16.44 EPS next 5Y6.80% ROE25.70% 52W Range25.55 - 35.60 Perf YTD23.83%
Dividend0.90 P/FCF123.25 EPS past 5Y-17.60% ROI15.00% 52W High-4.97% Beta0.74
Dividend %2.66% Quick Ratio0.70 Sales past 5Y-7.30% Gross Margin81.70% 52W Low32.41% ATR0.41
Employees59700 Current Ratio0.90 Sales Q/Q9.40% Oper. Margin24.80% RSI (14)53.46 Volatility0.87% 1.11%
OptionableYes Debt/Eq1.30 EPS Q/Q-32.40% Profit Margin15.90% Rel Volume0.32 Prev Close33.73
ShortableYes LT Debt/Eq1.23 EarningsNov 09 BMO Payout126.20% Avg Volume4.04M Price33.83
Recom1.60 SMA200.48% SMA500.08% SMA2005.47% Volume1,277,264 Change0.30%
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Nov-23-17 09:00AM  Top 10 Largest Pharmaceutical Companies By Revenue in 2017 Insider Monkey
Nov-22-17 10:57AM  Parkinson's Space in Focus as Acorda Stops Tozadenant Trial Zacks
Nov-21-17 07:12AM  The Zacks Analyst Blog Highlights: Walmart, NVIDIA, Procter & Gamble, Phillips 66 and AstraZeneca Zacks
Nov-20-17 04:03PM  Top Research Reports on Walmart, NVIDIA and Procter & Gamble Zacks
10:22AM  For Parkinson's Patients Like Jesse Jackson, Artificial Intelligence Shows Real Promise Forbes
09:25AM  Roche win boosts case for adding chemo to cancer immunotherapy Reuters
09:12AM  Foreign Stock Roundup: JD.com Beats Estimates, Petrobras & Infineon Miss Zacks
09:01AM  AstraZenecas Other Products in 3Q17 Market Realist
07:31AM  Performance of AstraZenecas Oncology Segment in 3Q17 Market Realist
Nov-17-17 11:24AM  ETFs with exposure to AstraZeneca Plc : November 17, 2017 Capital Cube
10:31AM  AstraZenecas Respiratory Segment in 3Q17 Market Realist
10:12AM  Why Its Time to Put Pfizer Inc. Stock on Your Watchlist InvestorPlace
09:53AM  Cancer Space Update: Label Expansion for Three Major Drugs Zacks
09:01AM  AstraZenecas Cardiovascular and Metabolic Diseases Segment Market Realist
07:32AM  How AstraZenecas Growth Platforms Performed in 3Q17 Market Realist
05:00AM  Texas Lawsuit Claims This Drugmaker Pushed Antipsychotic to Kids Bloomberg
Nov-16-17 02:30PM  AstraZenecas Performance by Segment in 3Q17 Market Realist
01:00PM  Why AstraZenecas Revenues Rose in 3Q17 Market Realist
11:26AM  AstraZenecas Valuation after 3Q17 Earnings Market Realist
10:59AM  AstraZeneca ticks another box as U.S. approves severe asthma drug Reuters
09:06AM  AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio Zacks
09:04AM  AstraZeneca Plc :AZN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 16, 2017 Capital Cube
07:13AM  Pharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal with Loxo Zacks
Nov-15-17 09:47AM  AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA Zacks
07:00AM  FASLODEX® (fulvestrant) Receives US FDA Approval for the Treatment of Advanced Breast Cancer in Combination with Abemaciclib Business Wire
03:48AM  AstraZeneca ticks another box as U.S. approves severe asthma drug Reuters
Nov-14-17 07:02PM  FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma PR Newswire
06:58PM  U.S. FDA approves AstraZeneca's asthma drug Reuters
03:44PM  Ionis Pharmaceuticals Inc. Sets Itself Up for Growth Motley Fool
09:29AM  Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day Zacks
03:02AM  Top LSE Dividend Picks For The Day Simply Wall St.
Nov-13-17 09:25AM  AstraZeneca Gets Positive CHMP Opinion for Asthma Candidate Zacks
08:02AM  Foreign Stock Roundup: Toyota, Gol Linhas Beat, AstraZeneca, Fresenius Miss Zacks
Nov-10-17 09:03AM  Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod Zacks
Nov-09-17 05:20PM  Tesaro Takes A Swipe At AstraZeneca's Ovarian Cancer Drug Sales Investor's Business Daily
02:00PM  AstraZeneca's Dividend Commitment Comes at a Cost Bloomberg
12:10PM  FTSE 100 closes lower as Burberry sinks the most in five years MarketWatch
10:00AM  Astra's Externalized Revenue Is Unsustainable Morningstar
09:00AM  AstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View Zacks
07:47AM  AstraZeneca rides China wave as rival GlaxoSmithKline struggles Reuters
07:42AM  It's Been a Fine Earnings Season, but Here Come the Retailers: Market Recon TheStreet.com
07:22AM  [$$] AstraZeneca lifts earnings guidance as sales decline slows Financial Times
06:48AM  AstraZeneca sales decline slows as it waits for medicine to work Reuters
05:48AM  Thousands of drugs face Brexit risk, makers to duplicate testing Reuters
05:48AM  AstraZeneca Stock Gains as Crestor Sales Decline Slows TheStreet.com
05:25AM  Astrazeneca tops Street 3Q forecasts Associated Press
04:07AM  AstraZeneca earnings fall amid patent protection losses Associated Press
02:52AM  [$$] AstraZeneca Posts Profit Rise The Wall Street Journal
02:17AM  AstraZeneca Q3 sales weak as it waits for medicine to work Reuters
Nov-08-17 05:01PM  Why Tesaro's $2 Million Cancer-Drug Miss Prompted Its Rivals To Topple Investor's Business Daily
09:03AM  What Analysts Recommend for AstraZeneca in 3Q17 Market Realist
07:34AM  How Will AstraZenecas Segments Perform in 3Q17? Market Realist
07:00AM  AstraZeneca Shares Scientific Updates from Its Extensive Cardiovascular, Renal and Metabolic Diseases (CVMD) Portfolio at AHA 2017 Business Wire
Nov-07-17 05:07PM  What Analysts Expect from AstraZenecas 3Q17 Earnings Market Realist
Nov-06-17 08:32AM  Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
07:00AM  Tax Reform: A Back Door To Killing Health Care, Medicare, And More Forbes
Nov-02-17 11:49AM  Clovis (CLVS) Q3 Loss Wider Than Expected, Revenues Miss Zacks
Nov-01-17 03:12PM  FDA Approves AstraZeneca's Blood Cancer Drug TheStreet.com
03:05PM  Incyte Tops Q3 Earnings & Sales, Extends AstraZeneca Deal Zacks
01:35PM  Does AstraZeneca PLCs (AZN) PE Ratio Signal A Buying Opportunity? Simply Wall St.
04:24AM  AstraZeneca asthma drug tralokinumab disappoints again Reuters
Oct-31-17 04:31PM  Incyte Rises On A Beat-And-Raise, Expanding Deal With AstraZeneca Investor's Business Daily
04:00PM  Incyte, AstraZeneca expand collaboration on potential lung cancer therapy American City Business Journals
02:54PM  AstraZeneca wins US approval for lymphoma drug Associated Press
09:26AM  Geron Shares Rise on Fast Track Designation -- Biotech Movers TheStreet.com
04:43AM  AstraZeneca plans new pivotal lung cancer trial with Incyte Reuters
Oct-30-17 11:03AM  3 High-Yield International Stocks Motley Fool
05:04AM  AstraZeneca licenses genetic disease drug to Mereo BioPharma Reuters
Oct-27-17 06:00PM  Merck Keytruda sales soar, but European application pulled Reuters
11:11AM  Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong Zacks
06:54AM  Merck posts quarterly loss vs. year-ago profit Reuters
03:00AM  Stocks With Rising Relative Strength: AstraZeneca Investor's Business Daily
Oct-26-17 10:19AM  ETFs with exposure to AstraZeneca Plc : October 26, 2017 Capital Cube
Oct-23-17 07:53AM  AstraZeneca among backers as Swiss cancer biotech raises $200 million Reuters
07:00AM  US FDA Approves New Easy-to-Use, Once-Weekly BYDUREON® BCise Injectable Medicine for Patients with Type-2 Diabetes Business Wire
Oct-20-17 05:28PM  Cancer Treatment Update: Second Gene Therapy Receives Approval Zacks
04:36PM  Novo Nordisk Stock: Performance in 3Q17 Market Realist
Oct-19-17 09:30AM  AstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review Zacks
Oct-18-17 01:05PM  AstraZeneca Announces New Data Showing US Preterm Infants at Significantly Greater Risk of RSV Hospitalizations Following 2014 Guidance Change Business Wire
10:32AM  [$$] Akzo/AstraZeneca: the chemical brothers Financial Times
09:12AM  What AstraZenecas 3Q17 Performance Tells Us Market Realist
09:07AM  Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever Benzinga
06:55AM  US FDA Accepts Regulatory Submission for LYNPARZA® (olaparib) in Metastatic Breast Cancer and Grants Priority Review Business Wire
02:46AM  Astra and Merck win speedy review for Lynparza in breast cancer Reuters
Oct-17-17 07:00AM  US FDA Accepts Supplemental Biologics License Application for IMFINZI® (durvalumab) in Locally Advanced, Unresectable Non-Small Cell Lung Cancer Business Wire
Oct-16-17 10:06AM  Foreign Stock Roundup: Roche Gets FDA Nod for Zika Test, Shell to Buy NewMotion Zacks
12:00AM  Drug Companies Fear Brexit Will Hit Medicine Trade Bloomberg
Oct-13-17 04:14PM  5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings Zacks
11:18AM  Cancer Space Update: Lung & Breast Cancer Studies in Focus Zacks
09:02AM  Lilly's Verzenio Gets Priority Review in First-Line Setting Zacks
Oct-09-17 11:54AM  AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation Zacks
09:14AM  TAGRISSO® (osimertinib) Granted Breakthrough Therapy Designation by US FDA for the 1st-Line Treatment of Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer Business Wire
12:00AM  [$$] AstraZeneca chief confident risks will pay off Financial Times
Oct-08-17 09:00AM  What's Behind AstraZeneca's September Rebound? Motley Fool
Oct-03-17 04:22PM  These Biotechs Slump As Report Suggests Discounting Their Drugs Investor's Business Daily
Oct-02-17 08:35AM  Tell us how Brexit will work, British companies demand Reuters
06:02AM  Drugs firm AstraZeneca wants three-year Brexit transition Reuters
Sep-29-17 11:32AM  Should You Be Tempted To Buy AstraZeneca PLC (LSE:AZN) At Its Current Price? Simply Wall St.
Sep-27-17 09:05AM  AstraZeneca's Bevespi Improves Lung Function in Phase III Study Zacks
Sep-25-17 10:00AM  3 High-Yield Stocks for Aggressive Investors Motley Fool
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; collaborations with FibroGen, Astellas, Pieris Pharmaceuticals Inc, Champions Oncology, Inc., and Takeda Pharmaceutical Company Limited; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.